Cas:1186502-26-0 2-(Methoxymethyl)-1H-pyrrolo[2,3-b]pyridin-5-amine manufacturer & supplier

Chemical Name:2-(Methoxymethyl)-1H-pyrrolo[2,3-b]pyridin-5-amine

CAS.NO:1186502-26-0

Synonyms:2-(Methoxymethyl)-1H-pyrrolo[2,3-b]pyridin-5-amine

Molecular Formula:C₉H₁₁N₃O

Molecular Weight:177.20300

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:63.93000

Exact Mass:177.09000

LogP:1.87270

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2-(Methoxymethyl)-1H-pyrrolo[2,3-b]pyridin-5-amine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-(Methoxymethyl)-1H-pyrrolo[2,3-b]pyridin-5-amine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-(Methoxymethyl)-1H-pyrrolo[2,3-b]pyridin-5-amine Use and application,2-(Methoxymethyl)-1H-pyrrolo[2,3-b]pyridin-5-amine technical grade,usp/ep/jp grade.

Related News: The clinical trial International Study of Phase 3 IV RigosErtib, or INSPIRE, was finalized following guidance received from the U.S. Food and Drug Administration and European Medicines Agency. 2-(Methoxymethyl)-1H-pyrrolo[2,3-b]pyridin-5-amine manufacturer Safety concerns about the J&J vaccine paired with flagging U.S. demand for vaccinations in general have slowed rollout of the one-shot vaccine to a crawl. Close to half of the 21 million doses produced for the United States sit unused. 2-(Methoxymethyl)-1H-pyrrolo[2,3-b]pyridin-5-amine supplier Under the high pressure of environmental protection, if Chinese API companies want to achieve sustainable operation, they must recognize the current situation, increase environmental investment, and carry out industrial upgrades, focusing on new product development, process improvement, CMO business and new technology research. And other businesses to carry out work to improve safety, environmental protection, quality, cost and other capabilities, so as to seize structural opportunities. 2-(Methoxymethyl)-1H-pyrrolo[2,3-b]pyridin-5-amine vendor Johnson & Johnson’s Darzalex has comfortably been the only CD38 multiple myeloma drug on the market for years until Sanofi hit the scene last year with Sarclisa. Now, just as the competition’s slated to intensify, the U.S. company is building its case with new patient survival data. 2-(Methoxymethyl)-1H-pyrrolo[2,3-b]pyridin-5-amine factory Roche’s second anti-tau antibody UCB0107, partnered with UCB, is also slated to enter deeper testing this year. Tau had appeared to have fresh promise as a rival of sorts to amyloid. Tau theory goes that neurofibrillary tangles that form inside cells clog up the brain, and clearing this can help Alzheimer’s patients.